Operating Cash Flow (Statement)

$2.88B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$2.88Bperiod endingJun 30, 2026

BIIB TTM Cash from Operations ($10.70M → $2.88B)

TTM operating cash flow (statement)

High-resolution chart · PNG

BIIB operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	424,031,000
Mar 31, 2001	437,565,000
Dec 31, 2000	365,939,000
Sep 30, 2000	300,595,000
Jun 30, 2000	295,015,000
Mar 31, 2000	260,216,000
Dec 31, 1999	272,288,000
Sep 30, 1999	204,845,000
Jun 30, 1999	190,745,000
Mar 31, 1999	155,345,000
Dec 31, 1998	167,845,000
Sep 30, 1998	134,032,000
Jun 30, 1998	126,932,000
Mar 31, 1998	114,032,000
Dec 31, 1997	97,632,000
Sep 30, 1997	141,539,000
Jun 30, 1997	101,739,000
Mar 31, 1997	81,039,000
Dec 31, 1996	46,539,000
Sep 30, 1996	4,949,000
Jun 30, 1996	-3,951,000
Mar 31, 1996	49,000
Dec 31, 1995	9,449,000
Sep 30, 1995	-7,614,000
Jun 30, 1995	386,000
Mar 31, 1995	1,986,000
Dec 31, 1994	34,886,000
Sep 30, 1994	49,600,000
Jun 30, 1994	48,800,000
Mar 31, 1994	64,600,000
Dec 31, 1993	47,600,000
Sep 30, 1993	67,900,000
Jun 30, 1993	70,600,000
Mar 31, 1993	55,000,000
Dec 31, 1992	43,100,000
Sep 30, 1992	18,200,000
Jun 30, 1992	6,000,000
Mar 31, 1992	8,000,000
Dec 31, 1991	5,900,000
Sep 30, 1991	6,000,000
Jun 30, 1991	9,400,000
Mar 31, 1991	15,100,000
Dec 31, 1990	10,700,000
Sep 30, 1990	6,800,000